Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Iván López-Méndez"'
Autor:
Karen D. Bernal-Contreras, Montserrat Berrospe-Alfaro, Regina López de Cárdenas-Rojo, Martha H. Ramos-Ostos, Misael Uribe, Iván López-Méndez, Eva Juárez-Hernández
Publikováno v:
Frontiers in Nutrition, Vol 11 (2024)
BackgroundAlthough body composition (BC) has been associated with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), there is little evidence of differences in BC in patients with MASLD regarding body mass index (BMI). The aim of this
Externí odkaz:
https://doaj.org/article/832b483bfa01411783cec3db55436e68
Autor:
Ramón Mena-Ramírez, Andres Macari-Jorge, Eva Juárez-Hernández, Misael Uribe, Iván López-Méndez
Publikováno v:
The Turkish Journal of Gastroenterology, Vol 34, Iss 8, Pp 866-872 (2023)
Externí odkaz:
https://doaj.org/article/ad86b63d897d4b1e9903e5f58c9ea75e
Autor:
Alejandra Mijangos-Trejo, Raúl Gómez-Mendoza, Martha Helena Ramos-Ostos, Graciela Castro-Narro, Misael Uribe, Eva Juárez-Hernández, Iván López-Méndez
Publikováno v:
Diagnostics, Vol 14, Iss 7, p 762 (2024)
Background: The triglyceride–glucose index (TyG) and a combination of body mass index (BMI) and waist circumference (WC) have been proposed as predictive scores for liver steatosis (LS). The aim of this study was to determine the diagnostic accurac
Externí odkaz:
https://doaj.org/article/d55d1be8a7134040841532e4d4d0de37
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent metabolic disease, although prevalence could change according to region, nowadays is considered a public health problem whose real impact on the health system is unknown. NAFLD has a mul
Externí odkaz:
https://doaj.org/article/7ab808e03d7542008ab4b40ef68a9da9
Autor:
Eva Juárez-Hernández, Alain P. Velázquez-Alemán, Graciela Castro-Narro, Misael Uribe, Iván López-Méndez
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
Nowadays, non-alcoholic fatty liver disease is one of the first causes of liver transplant worldwide; many efforts have been done to find the perfect drug for this multifactorial disease. Presently we just have a few drugs that could be used in speci
Externí odkaz:
https://doaj.org/article/7fe30ad1c2a74191a154fa7391fcf1b2
Publikováno v:
Endoscopia, Vol 34, Iss 4 (2022)
Endoscopic retrograde cholangiopancreatography in patients with surgical alterations in the normal biliary anatomy is technically challenging. We describe the case of a 73-year-old patient with an afferent limb syndrome secondary to a Whipple procedu
Externí odkaz:
https://doaj.org/article/887668bbb25e4e94b63696205a30de75
Publikováno v:
Endoscopia, Vol 34, Iss 4 (2022)
Endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS) is a therapeutic tool that allows for biliary drainage when conventional endoscopic retrograde cholangiopancreatography is technically or clinically unsuccessful. For those cases where re-int
Externí odkaz:
https://doaj.org/article/1427152882d94aa890f26311dd853596
Autor:
Julia Zuarth-Vázquez, Lidia Moreno-Castañeda, Juan Pablo Soriano-Márquez, Alain Velázquez-Alemán, Martha Helena Ramos-Ostos, Misael Uribe, Iván López-Méndez, Eva Juárez-Hernández
Publikováno v:
Life, Vol 13, Iss 4, p 1048 (2023)
Background: The association of low–normal thyroid function (LNTF) with non-alcoholic fatty liver disease (NAFLD) or metabolic dysfunction-associated fatty liver disease (MAFLD) is controversial; thus, the aim of this study is to determine this asso
Externí odkaz:
https://doaj.org/article/8b9ebddf1ad747879ebb8a1784ec2682
Autor:
Eric López-Méndez, Eduardo López-Méndez, Iván López-Méndez, Pablo Hernández-Reyes, Jaime Galindo-Uribe, Vanessa Angulo-Ramírez, Lourdes Ávila-Escobedo, Misael Uribe
Publikováno v:
Annals of Hepatology, Vol 5, Iss 1, Pp 50-52 (2006)
Ischemic hepatitis is an infrequent entity, usually associated with low cardiac out put. We present a case of a 57 year-old man with chronic renal failure and cardiac tamponade who developed elevation of serum alanine transferase level of 5,054 U/L,
Externí odkaz:
https://doaj.org/article/705407006b024af7a09bd14f077e3bc8
Autor:
Ana Luisa Ordoñez-Vázquez, Eva Juárez-Hernández, Julia María Zuarth-Vázquez, Martha Helena Ramos-Ostos, Misael Uribe, Graciela Castro-Narro, Iván López-Méndez
Publikováno v:
International Journal of Environmental Research and Public Health; Volume 19; Issue 19; Pages: 12221
Background: Non-alcoholic fatty liver disease (NAFLD) is considered the hepatic manifestation of metabolic syndrome. Recently, the term metabolic dysfunction-associated fatty liver disease (MAFLD) has been proposed and adapted to body mass index (BMI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::414d8ec82ccc720a8609093f12bbaa3c
https://doi.org/10.3390/ijerph191912221
https://doi.org/10.3390/ijerph191912221